Estadístiques de Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases
Visites totals
| views | |
|---|---|
| Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases | 31 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 8 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Hecht_eo_phas.pdf | 29 |
| Hecht_eo_phas.pdf(legacy) | 19 |
Vistes principals per país
| views | |
|---|---|
| United States | 14 |
| Spain | 7 |
| Argentina | 2 |
| Australia | 2 |
| India | 2 |
| Mongolia | 2 |
| European Union | 1 |
| Netherlands | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Mountain View | 6 |
| Girona | 4 |
| Barcelona | 3 |
| Milwaukee | 2 |
| Pinjarra | 2 |
| Suipacha | 2 |
| Ulaanbaatar | 2 |
| Ann Arbor | 1 |
| Hyderabad | 1 |
| Menlo Park | 1 |
| Redmond | 1 |
| Sacramento | 1 |
| San Ramon | 1 |
| Thane | 1 |